Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC.

Ross, A; Sardi, A; Nieroda, C; Merriman, B; Gushchin, V

Ross, A; Sardi, A; Nieroda, C; Merriman, B; Gushchin, V.

Affiliation

Ross A; Division of Surgery, Department of Surgical Oncology, The Institute for Cancer Care, Mercy Medical Center, Baltimore, Maryland 21202, USA.

Eur J Surg Oncol ; 36(8): 772-6, 2010 Aug.

Article in En | MEDLINE | ID: mdl-20561764

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Appendiceal Neoplasms/immunology; Appendiceal Neoplasms/surgery; Biomarkers, Tumor/blood; Chemotherapy, Cancer, Regional Perfusion; Hyperthermia, Induced; Peritoneal Neoplasms/immunology; Peritoneal Neoplasms/surgery; Adult; Aged; Appendiceal Neoplasms/drug therapy; Appendiceal Neoplasms/mortality; Appendiceal Neoplasms/pathology; CA-125 Antigen/blood; CA-19-9 Antigen/blood; Carcinoembryonic Antigen/blood; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion/methods; Confounding Factors, Epidemiologic; Female; Humans; Male; Middle Aged; Patient Selection; Peritoneal Neoplasms/drug therapy; Peritoneal Neoplasms/metabolism; Peritoneal Neoplasms/mortality; Predictive Value of Tests; Prospective Studies; Survival Analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Appendiceal Neoplasms / Peritoneal Neoplasms / Chemotherapy, Cancer, Regional Perfusion / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Hyperthermia, Induced Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Surg Oncol Year: 2010 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google